Variety of TEM-, SHV-, and CTX-M-type β-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan

被引:38
作者
Ma, L
Chang, FY
Fung, CP
Chen, TL
Lin, JC
Lu, PL
Huang, LY
Chang, JC
Siu, LK
机构
[1] Natl Hlth Res Inst, Div Clin Res, Taipei 11529, Taiwan
[2] Tri Serv Gen Hosp, Natl Def Med Ctr, Div Infect Dis & Trop Med, Dept Internal Med, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Infect Dis Sect, Dept Med, Taipei, Taiwan
[4] Natl Yang Ming Univ, Taipei 112, Taiwan
[5] Kaohsiung Med Univ Hosp, Dept Internal Med, Taipei, Taiwan
关键词
D O I
10.1089/mdr.2005.11.31
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
A total of 171 hospitals' isolates of E. coli, K. pneumoniae, and E. cloacae with a minimum inhibitory concentration (MIC) of >= 2 mu g/ml for ceftazidime or cefotaxime were evaluated for the production of beta-lactamases. PCR amplification with specific primers for the bla(SHV), bla(TEM), and bla(CTX) genes revealed that a total of 53, 81, and 43 of these genes were amplified, respectively. Sequencing results confirmed that TEM-1, CTX-M-3 and -14, SHV-1, -5, -11, -12, and -33, OXY-1a, and LEN-1 were presented among these isolates. No specific large cluster of isolates carried the same beta-lactamases, indicating the wide diversity of the collected strains. Plasmid spread between E. coli and K. neumoniae was identified in few isolates. Combinations of TEM, SHV, and CTX beta-lactamase genes, including extended-spectrum beta-lactamase genes, were observed in all three species.
引用
收藏
页码:31 / 39
页数:9
相关论文
共 33 条
[1]
AUSUBEL FM, 1995, MINIPREP BACTERIAL G
[2]
Are SHV β-lactamases universal in Klebsiella pneumoniae? [J].
Babini, GS ;
Livermore, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) :2230-2230
[3]
A NEW PLASMIDIC CEFOTAXIMASE FROM PATIENTS INFECTED WITH SALMONELLA-TYPHIMURIUM [J].
BAUERNFEIND, A ;
CASELLAS, JM ;
GOLDBERG, M ;
HOLLEY, M ;
JUNGWIRTH, R ;
MANGOLD, P ;
ROHNISCH, T ;
SCHWEIGHART, S ;
WILHELM, R .
INFECTION, 1992, 20 (03) :158-163
[4]
Extended-spectrum β-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime [J].
Blahová, J ;
Králiková, K ;
Krcméry, V ;
Schäfer, V .
JOURNAL OF CHEMOTHERAPY, 1999, 11 (02) :97-102
[5]
A novel CTX-M β-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil [J].
Bonnet, R ;
Sampaio, JLM ;
Labia, R ;
De Champs, C ;
Sirot, D ;
Chanal, C ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1936-1942
[6]
TEM-28 from an Escherichia coli clinical isolate is a member of the his-164 family of TEM-1 extended-spectrum beta-lactamases [J].
Bradford, PA ;
Jacobus, NV ;
Bhachech, N ;
Bush, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :260-262
[7]
CTX-M-5, a novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia [J].
Bradford, PA ;
Yang, YJ ;
Sahm, D ;
Grope, I ;
Gardovska, D ;
Storch, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1980-1984
[8]
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein [J].
Bradford, PA ;
Urban, C ;
Mariano, N ;
Projan, SJ ;
Rahal, JJ ;
Bush, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :563-569
[9]
SHV-7, A NOVEL CEFOTAXIME-HYDROLYZING BETA-LACTAMASE, IDENTIFIED IN ESCHERICHIA-COLI ISOLATES FROM HOSPITALIZED NURSING-HOME PATIENTS [J].
BRADFORD, PA ;
URBAN, C ;
JAISWAL, A ;
MARIANO, N ;
RASMUSSEN, BA ;
PROJAN, SJ ;
RAHAL, JJ ;
BUSH, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (04) :899-905
[10]
Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China [J].
Chanawong, A ;
M'Zali, FH ;
Heritage, J ;
Xiong, JH ;
Hawkey, PM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) :630-637